Ryan Specialty Holdings Inc. (NYSE:RYAN) Stock Has Consensus Target Price of $52.21 According to Brokerages

Key Points

• Analyst consensus is “Hold” among 19 firms, with 10 hold, eight buy and one sell rating; the average 12-month price target is $52.21.
• Ryan Specialty’s third-quarter adjusted EPS of $0.51 exceeded estimates, while revenue rose 4.7% year over year to about $790 million but came in slightly below expectations.
• Organic growth slowed to 4% and the company remains highly leveraged with roughly $3.7 billion in debt, although management maintained its full-year mid-single-digit organic revenue growth outlook and returned $173.7 million to shareholders.

Shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Get Free Report) have been given an average recommendation of "Hold" by the nineteen ratings firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $52.21.

Several research firms have recently commented on RYAN. Cantor Fitzgerald upped their price target on shares of Ryan Specialty from $34.00 to $41.00 and gave the stock a "neutral" rating in a research report on Monday, August 3rd. Keefe, Bruyette & Woods lifted their price objective on shares of Ryan Specialty from $48.00 to $54.00 and gave the company an "outperform" rating in a research report on Friday, July 31st. Wells Fargo & Company reduced their target price on shares of Ryan Specialty from $43.00 to $41.00 and set an "equal weight" rating for the company in a research note on Monday, October 12th. UBS Group upped their target price on shares of Ryan Specialty from $50.00 to $55.00 and gave the stock a "buy" rating in a research report on Monday, August 3rd. Finally, Citigroup raised their price target on shares of Ryan Specialty from $50.00 to $53.50 and gave the company a "buy" rating in a research note on Monday, August 3rd.

Hedge Funds Weigh In On Ryan Specialty

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Allworth Financial LP raised its stake in Ryan Specialty by 70.0% during the 2nd quarter. Allworth Financial LP now owns 787 shares of the company's stock valued at $30,000 after acquiring an additional 324 shares in the last quarter. Fortitude Family Office LLC bought a new position in shares of Ryan Specialty in the third quarter worth $34,000. Parallel Advisors LLC grew its stake in shares of Ryan Specialty by 54.9% in the first quarter. Parallel Advisors LLC now owns 1,013 shares of the company's stock worth $34,000 after purchasing an additional 359 shares in the last quarter. Integrated Wealth Concepts LLC bought a new position in shares of Ryan Specialty in the second quarter worth $73,000. Finally, GAMMA Investing LLC increased its holdings in shares of Ryan Specialty by 90.2% during the second quarter. GAMMA Investing LLC now owns 2,107 shares of the company's stock valued at $80,000 after purchasing an additional 999 shares during the period. 84.82% of the stock is owned by institutional investors.

Key Stories Impacting Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Third-quarter adjusted earnings per share were $0.51, exceeding the $0.49 analyst consensus. Revenue rose 4.7% year over year to approximately $790 million, while net income increased 40.6% to $88 million. Ryan Specialty Q3 Adjusted Earnings, Revenue Rise
• Positive Sentiment: Ryan Specialty returned $173.7 million to shareholders during the quarter, including $150 million in stock repurchases and $23.7 million in dividends and distributions. The company also maintained its full-year outlook for mid-single-digit organic revenue growth. Ryan Specialty Q3 Revenue Rises 4.7% to $790 Million
• Neutral Sentiment: Revenue was slightly below the approximately $793 million analyst estimate, making the quarter a mixed result despite the EPS beat. Ryan Specialty earnings results
• Negative Sentiment: Organic revenue growth slowed to 4%, a deceleration that raised concerns about the company’s underlying expansion rate. Management also indicated that the full-year adjusted EBITDAC margin could decline modestly from the prior year. Ryan Specialty organic growth slows to 4% in Q3 earnings beat
• Negative Sentiment: The balance sheet remains highly leveraged, with approximately $3.7 billion of outstanding debt and a debt-to-equity ratio of 3.51. That leverage may limit flexibility if growth or profitability weakens. Ryan Specialty posts mixed Q3 2026 results

Ryan Specialty Price Performance

Shares of Ryan Specialty stock opened at $43.19 on Friday. The stock has a market capitalization of $11.05 billion, a P/E ratio of 59.99, a PEG ratio of 0.87 and a beta of 0.61. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 3.51. The business's fifty day moving average price is $40.41 and its 200 day moving average price is $39.20. Ryan Specialty has a twelve month low of $29.28 and a twelve month high of $58.94.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Thursday, October 29th. The company reported $0.51 EPS for the quarter, topping analysts' consensus estimates of $0.49 by $0.02. The company had revenue of $789.96 million for the quarter, compared to analysts' expectations of $792.99 million. Ryan Specialty had a return on equity of 43.97% and a net margin of 7.55%. During the same quarter in the previous year, the firm posted $0.47 earnings per share. As a group, research analysts anticipate that Ryan Specialty will post 2.17 earnings per share for the current year.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.

Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.